Antidiabetic potential of a novel hydroxyphenyl-bi-benzopyran-hexol compound from Cassia fistula as an α-amylase inhibitor: Integrated in silico screening and in vitro validation using a nonlinear regression model
Journal of Ayurveda and Integrative Medicine · 2026-07 · 17 (4) · 101366
DOI: 10.1016/j.jaim.2026.101366 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Ayurveda and Integrative Medicine, 2026-07. Verfasst von Rajamanickam Baskar und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gunapadam (Pharmacology), Government Siddha Medical College, The Tamil Nadu Dr. MGR Medical University, Chennai, Tamil Nadu, 600032, In…. Die Arbeit nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gunapadam (Pharmacology), Government Siddha Medical College, The Tamil Nadu Dr. MGR Medical University, Chennai, Tamil Nadu, 600032, India.
- PG and Research Department of Biotechnology, Sri Sankara Arts and Science College, University of Madras, Enathur, Kanchipuram, Tamil Nadu, 631561, India.
- Government Siddha Medical College, The Tamil Nadu Dr. MGR Medical University, Chennai, Tamil Nadu, 600032, India.
- Arignar Anna Government Hospital of Indian Medicine, Chennai, Tamil Nadu, 600106, India.
- PG and Research Department of Microbiology, Sri Sankara Arts and Science College, University of Madras, Enathur, Kanchipuram, Tamil Nadu, 631561, India.
- PG and Research Department of Biotechnology, Sri Sankara Arts and Science College, University of Madras, Enathur, Kanchipuram, Tamil Nadu, 631561, India. Electronic address: ramesh@sankaracollege.edu.in.
Zitieren
APA
Baskar, R., Harini, M., Selvapriya, S. S., Hemadevi, T., Rajalakshmi, A., Kavitha, K., Puvanakrishnan, R., & Ramesh, B. (2026). Antidiabetic potential of a novel hydroxyphenyl-bi-benzopyran-hexol compound from Cassia fistula as an α-amylase inhibitor: Integrated in silico screening and in vitro validation using a nonlinear regression model. Journal of Ayurveda and Integrative Medicine, 17(4), 101366. https://doi.org/10.1016/j.jaim.2026.101366
Vancouver
Baskar R, Harini M, Selvapriya SS, Hemadevi T, Rajalakshmi A, Kavitha K, et al. Antidiabetic potential of a novel hydroxyphenyl-bi-benzopyran-hexol compound from Cassia fistula as an α-amylase inhibitor: Integrated in silico screening and in vitro validation using a nonlinear regression model. Journal of Ayurveda and Integrative Medicine. 2026;17(4):101366. doi:10.1016/j.jaim.2026.101366
BibTeX
@article{Baskar2026,
author = {Baskar, Rajamanickam and Harini, Manoharan and Selvapriya, Sikkal Selvaraaju and Hemadevi, Thangarasu and Rajalakshmi, Arumugam and Kavitha, Kuppuswamy and Puvanakrishnan, Rengarajulu and Ramesh, Balasubramanian},
title = {Antidiabetic potential of a novel hydroxyphenyl-bi-benzopyran-hexol compound from Cassia fistula as an α-amylase inhibitor: Integrated in silico screening and in vitro validation using a nonlinear regression model},
journal = {Journal of Ayurveda and Integrative Medicine},
year = {2026},
volume = {17},
number = {4},
pages = {101366},
doi = {10.1016/j.jaim.2026.101366}
}
EUVIMED